BioReliance Updates Big Blue Mouse Assay Service

News
Article

BioReliance updates Big Blue Mouse Assay service to meet OECD test requirements.


SPOTLIGHT EVENT

IVT’s 19th AnnualValidation Week

RELATED ARTICLES

More in GMPs/Validation

BioReliance

, SAFC’s biologics and early-development services business, has qualified the Big Blue Mouse Transgenic Rodent Mutation (TRM) assay to meet the new Organization for Economic Co-Operation and Development (OECD) Test Guideline 488 requirements for evaluation of

in vivo

mutagenicity.

Big Blue is identified in OECD Test Guideline 488 and recommended by the European Chemicals Agency as an accepted assay for evaluating mutagenicity in somatic and male germ cell tissues.

BioReliance acquired the exclusive ownership of the Big Blue TRM assay and rodents from Agilent in March 2013.

Source: BioReliance

Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content